Sodium Acetate (Hospira, Inc.)


Welcome to the PulseAid listing for the Sodium Acetate drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: sodium acetate
SUBSTANCE NAME: SODIUM ACETATE ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-11-19
END MARKETING DATE: 0000-00-00


Sodium Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Acetate from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 164(mg/mL)
START MARKETING DATE: 2013-11-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-3299_0c2ccd5d-49c7-4b73-bc12-67e478910cf4
PRODUCT NDC: 0409-3299
APPLICATION NUMBER: NDA018893

Other SODIUM ACETATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Sodum Acetate
Hospira, Inc.Sodium Acetate